Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis

Federal Circuit Finds Velcade Patent Not Obvious Under Lead Compound Analysis


In Millennium Pharmaceuticals, Inc. v. Sandoz , the Federal Circuit reversed the district court decision that invalidated one of the Orange Book-listed patents covering the anti-cancer drug Velcade.



from Biotech News